Dennis D. Kim, Chief Medical Officer at CymaBay Therapeutics, Inc. (CBAY), sold 100 shares at $8.99 ($899) on 2023-03-28, disclosed to the SEC on 2023-03-30.
Open-market sale of $899 CBAY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZFGN | BUY | 2017-07-12 | $34K | — | Filing → |
| ZFGN | BUY | 2017-05-11 | $44K | — | Filing → |
| ZFGN | SELL | 2015-09-17 | $1.6M | — | Filing → |